Advertisement

Diabetologia

, Volume 30, Issue 2, pp 51–65 | Cite as

On the way to the automated (blood) glucose regulation in diabetes: the dark past, the grey present and the rosy future

XII Congress of the International Diabetes Federation, Madrid, 22–28 September 1985
  • E. F. Pfeiffer
Review
  • 111 Downloads

Summary

The development of the artificial pancreas represents an important step forward in modern diabetology. The practical and theoretical findings obtained by its application to Type 1 (insulin-dependent) diabetic patients has given new insights into modes of insulin secretion, pathophysiology of diabetes mellitus, and new forms of treatment, i. e. the development of portable insulin pumps and intensified conventional insulin therapy. All of these therapies provided better results than conventional insulin administration. However, there is no doubt that the restoration of normoglycaemia in a real sense is obtainable only by an implantable artificial pancreas or pancreas transplantation. The development of the implantable artificial pancreas, on the other hand, is dependent upon the development of a reliably working permanently implantable glucose sensor. The first attempts in that direction have opened new vistas as to the differences between blood and interstitial tissue glucose measurements, displaying different modes of regulation under normal and pathologic conditions. A number of barriers have to be overcome until the final goal has been attained: to obtain, by automated blood glucose control, narrow glycaemic fluctuations of the normal subject, and to prevent, hopefully, relentless diabetic complications.

Keywords

Insulin Secretion Insulin Therapy Diabetic Complication Blood Glucose Control Glucose Measurement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Kruse-Jarres JD, Molnar GD (eds) (1977) Blood glucose monitoring. Horm Metab Res [Suppl Ser] 7: 1–157Google Scholar
  2. 2.
    Pfeiffer EF, Thum C, Raptis S, Beischer W, Ziegler R (1976) Hypoglycemia in diabetics. Horm Metab Res [Suppl Ser] 6: 112–126Google Scholar
  3. 3.
    Pfeiffer EF, Thum C, Clemens AH (1974) The artificial beta cella continuous control of blood sugar by external regulation of insulin infusion (glucose controlled insulin infusion system). Horm Metab Res 6: 339–342Google Scholar
  4. 4.
    Pfeiffer EF, Thum C, Clemens AH (1974) Die künstliche Beta-Zelle: Ein automatisch gesteuertes Insulin-Infusionssystem zur Behandlung von Zuckerkranken. Naturwissenschaften 61: 455–456Google Scholar
  5. 5.
    Albisser AM, Leibel BS, Ewart TG, Davidovac Z, Bote CK, Zingg W (1974) An artificial endocrine pancreas. Diabetes 23: 389–396Google Scholar
  6. 6.
    Kraegen EW, Campbell LV, Chia YO, Meler H, Lazarus L (1977) Control of blood glucose in diabetics using an artificial pancreas. Aust NZ J Med 7: 280–286Google Scholar
  7. 7.
    Mirouze J, Selam JL, Pham TC, Cavadore D (1977) Evaluation of exogenous insulin homoeostasis by the artificial pancreas in insulin dependent diabetes. Diabetologia 13: 273–278Google Scholar
  8. 8.
    Kawamori R, Shichiri M, Goriya Y, Yamasaki Y, Shigeta Y, Abe H (1978) Importance of insulin secretion based on the rate of change in blood glucose concentration in glucose tolerance assessed by the artificial beta cell. Acta Endocrinol 87: 339–351Google Scholar
  9. 9.
    Sailer D, Berg G (1979) Computer-controlled bedside monitoring and infusion system. Horm Metab Res [Suppl Ser] 8: 45–48Google Scholar
  10. 10.
    Slama G, Klein JC, Delage A, Rottembourg J, Marenani A, Jacobs C (1979) The use of the artificial pancreas in uremic diabetic patients. Horm Metab Res [Suppl Ser] 8: 178–183Google Scholar
  11. 11.
    Kadish AH (1964) Automation control of blood sugar LA servomechanism for glucose monitoring and control. Am J Med Electronics 3: 82–86Google Scholar
  12. 12.
    Kerner W, Thum C, Tamas G, Beischer W, Clemens AH, Pfeiffer EF (1976) Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta-cell. Horm Metab Res 8: 256–261Google Scholar
  13. 13.
    Kerner W, Beischer W, Herfarth C, Pfeiffer EF (1979) Application of an artificial endocrine pancreas in the management of the diabetic surgical patient. Horm Metab Res [Suppl Ser] 8: 159–161Google Scholar
  14. 14.
    Beyer J, Wolf E, Cordes U, Hassinger W (1979) The artificial beta cell (Biostator) in the adjustment of instable diabetics — results after 20 months. Horm Metab Res [Suppl Ser] 8: 127–131Google Scholar
  15. 15.
    Lambert AG, Buysschaert M, Lambotte L (1979) Use of an artificial pancreas as a tool to determine subcutaneous insulin dose in juvenile diabetes. Diabetes Care 2: 256–264Google Scholar
  16. 16.
    Christiansen JS, Svendsen PA, Mathiesen E, Rubin P, Decken T (1981) Comparison of 24-h insulin requirements in IDDM patients during control by an artificial beta cell and during conventional therapy. Horm Metab Res 13: 537–541Google Scholar
  17. 17.
    Kraegen EW, Chisholm DY, McNamam ME (1981) Training of insulin delivery with meals. Horm Metab Res 13: 365–367Google Scholar
  18. 18.
    Kerner W, Moll U, Navascues I, Pfeiffer EF (1984) Importance of early postprandial insulin delivery in insulin-dependent diabetics. Klin Wochenschr 62: 738–744Google Scholar
  19. 19.
    Kerner W, Schulte M, Schock D, Pfeiffer EF (1982) Variations of insulin requirements in insulin dependent diabetics for meals taken at different times of the day. Horm Metab Res [Suppl Ser] 12: 228–230Google Scholar
  20. 20.
    Clarke WL, Raymond MW, Santiago JU (1980) Overnight basal insulin requirements in fasting insulin-dependent diabetics. Diabetes 29: 78–80Google Scholar
  21. 21.
    Kerner W, Navascues I, Torres AA, Pfeiffer EF (1984) Studies on the pathogenesis of the dawn phenomenon in insulin-dependent diabetic patients. Metabolism 33: 458–464Google Scholar
  22. 22.
    Meissner C, Thum C, Beischer W, Winkler G, Schröder KE, Pfeiffer EF (1975) The antidiabetic action of somatostatin-assessed by the artificial pancreas. Diabetes 24: 988–996Google Scholar
  23. 23.
    Marliss EB, Murray FT, Stokes EF, Zinman B, Nakhooda AF, Denoga A, Leibel BS, Albisser AM (1977) Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas. Diabetes 26: 663–672Google Scholar
  24. 24.
    Schock D, Schulte M, Kerner W, Maier V, Pfeiffer EF (1981) The influence of normoglycemia on serum concentrations of growth hormone, glucagon and free fatty acids in juvenile diabetics. Irsigler K, Kunz KN, Owens DR, Regal H (eds) New approaches to insulin therapy. MTP Press, Lancaster, pp 211–218Google Scholar
  25. 25.
    Hanna AK, Zinman B, Nakhooda AF, Minuk HL, Stokes EF, Albisser AM, Leibel BS, Marliss EB (1980) Insulin, glucagon and amino acids during glycemic control by the artificial pancreas in diabetic man. Metabolism 29: 321–332Google Scholar
  26. 26.
    Horwitz DL (1979) Insulin responses to mixed meals: comparison of an artificial beta cell and normal beta cells. Horm Metab Res [Suppl Ser] 8: 68–71Google Scholar
  27. 27.
    Foss MC, Vlachokosta FV, Cunningham L, Aoki TT (1982) Restoration of glucose homeostasis in insulin-dependent diabetic subjects. Diabetes 31: 46–52Google Scholar
  28. 28.
    Bote CK, Leibel BS, Zingg W, Gander RE, Albisser AM (1976) Comparison of peripheral and portal routes of insulin infusion by a computer-controlled insulin infusion system (artificial endocrine pancreas). Diabetes 25: 691–700Google Scholar
  29. 29.
    Schock A, Schultz M, Kerner W, Maier V, Pfeiffer EF (1979) The effect of three days of blood glucose normalization by means of an artificial endocrine pancreas on the concentrations of growth hormone, glucagon and cortisol in juvenile diabetics. Horm Metab Res [Suppl Ser] 8: 93–96Google Scholar
  30. 30.
    Kerner W (1984) Artificial endocrine pancreas and portal insulin pumps: effect of improved glucose control on hormonal and metabolic abnormalities and the development of microvascular complications in Type I diabetes. In: Federlin K, Scholtholt J (eds) The importance of islets of Langerhans for modern endocrinology. Raven Press, New York, pp 189–204Google Scholar
  31. 31.
    Mirouze JJ (1983) Insulin treatment: non-stop revolution. Diabetologia 25: 209–221Google Scholar
  32. 32.
    Lauritzen T, Frost-Larsen K, Larsen HW, Deckert T, Steno Study Group (1983) Effect of 1 year of near-normal blood glucose levels on retinopathy in insulin-dependent diabetics. Lancet 1: 200–204Google Scholar
  33. 33.
    The Kroc Collaborative Study Group (1984) Blood glucose control and the evolution of diabetic retinopathy and albuminuria. A preliminary multicenter trial. N Engl J Med 311: 365–372Google Scholar
  34. 34.
    Pfeiffer EF, Kerner W (1979) The impact of insulin infusion systems upon the theory and practice of diagnosis and treatment of diabetes mellitus. In: Waldhäusl WK (ed) Diabetes 1979. Proceedings of the 10th Congress of the IDF. Excerpta Medica, Amsterdam, OxfordGoogle Scholar
  35. 35.
    Arias P, Kerner W, Zier H, Navascues I, Pfeiffer EF (1984) Incidence of hypoglycemic episodes in diabetic patients under continuous subcutaneous insulin infusion and intensified conventional insulin treatment: assessment by means of semiambulatory 24 hours continuous blood glucose monitoring. Diabetes Care 8: 134–140Google Scholar
  36. 36.
    Clark LC, Lyons C (1962) Electrode systems for continuous monitoring in cardiovascular surgery. Ann NY Acad Sci 102: 29–45Google Scholar
  37. 37.
    Updike SJ, Hicks GP (1967) The enzyme electrode. Nature 214: 986–988Google Scholar
  38. 38.
    Clemens AH, Chang PH, Kerner W, Myers RW, Pfeiffer EF (1977) Development of an electrochemical blood glucose analyzer and new control algorithms for a glucose controlled insulin infusion (artificial beta-cell). In: Bajaj JS (ed) Diabetes. Proceedings of the IX Congress of the International Diabetes Federation. Excerpta Medica, Amsterdam Oxford, pp 481–488Google Scholar
  39. 39.
    Pfeiffer EF, Beischer W, Kerner W (1977) The artificial endocrine pancreas in clinical research. Horm Metab Res [Suppl Ser] 7: 95–112Google Scholar
  40. 40.
    Pozza G, Bosi E, Secchi A, Piatti PM, Touraine JL, Gebet A, Pontiroli AE, Dubernard JM, Traeger J (1985) Metabolic control of Type I (insulin dependent) diabetes after pancreas transplantation. Br Med J 291: 510Google Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • E. F. Pfeiffer
    • 1
  1. 1.University of UlmUlmFRG

Personalised recommendations